Jane Street
SGMO

Jane Street’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Jane Street’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.3K Buy
236,200
+194,100
+461% +$77.2K ﹤0.01% 10908
2025
Q4 		$17.7K Buy
+42,100
New +$22.3K ﹤0.01% 10754
2025
Q2 		– Sell
-55,400
Closed -$36.3K – 10763
2025
Q1 		$36.3K Sell
55,400
-44,300
-44% -$46.9K ﹤0.01% 9065
2024
Q4 		$102K Buy
99,700
+78,200
+364% +$143K ﹤0.01% 8759
2024
Q3 		$18.6K Buy
+21,500
New +$15.8K ﹤0.01% 9303
2022
Q4 		– Sell
-22,000
Closed -$108K – 10054
2022
Q3 		$108K Buy
22,000
+7,700
+54% +$39.6K ﹤0.01% 8611
2022
Q2 		$59K Sell
14,300
-23,300
-62% -$101K ﹤0.01% 8874
2022
Q1 		$218K Sell
37,600
-42,600
-53% -$253K ﹤0.01% 8914
2021
Q4 		$602K Buy
80,200
+51,300
+178% +$446K ﹤0.01% 6913
2021
Q3 		$260K Sell
28,900
-35,400
-55% -$350K ﹤0.01% 8443
2021
Q2 		$770K Buy
64,300
+29,200
+83% +$331K ﹤0.01% 6396
2021
Q1 		$440K Sell
35,100
-186,400
-84% -$2.51M ﹤0.01% 7028
2020
Q4 		$3.46M Buy
221,500
+76,100
+52% +$891K ﹤0.01% 2617
2020
Q3 		$1.37M Buy
145,400
+76,600
+111% +$828K ﹤0.01% 3582
2020
Q2 		$616K Buy
+68,800
New +$638K ﹤0.01% 4757
2018
Q3 		– Sell
-27,000
Closed -$383K – 5647
2018
Q2 		$383K Buy
+27,000
New +$449K ﹤0.01% 3877

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's SGMO Position: Q1 2026 in Review

Jane Street sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 2,918,127 shares — an estimated $1.16M sold.

Jane Street first reported a position in SGMO in Q2 2013 and held it in 34 quarters. The position peaked at $2.89M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Jane Street reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 2,918,127 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $1.16M.
  • Jane Street first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 34 quarters.
  • Jane Street's SANGAMO THERAPEUTICS INC position peaked at $2.89M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.